Differences in radiation, cisplatin, and cetuximab sensitivity between subpopulations of head and neck cancer cells

被引：0
|
作者：
Nilsson, C. [1 ]
La Fleur, L. [1 ]
Roberg, K. [1 ]
机构：
[1] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71219-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
418
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [21] Ketogenic diet sensitizes FaDu human head and neck cancer xenografts to cisplatin as well as ionizing radiation combined with cetuximab
    Ma, Daniel C.
    Rodman, Samuel N.
    Buatti, John M.
    Anderson, Carryn
    Allen, Bryan G.
    Spitz, Douglas R.
    Fath, Melissa A.
    CANCER RESEARCH, 2015, 75
  • [22] Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro
    Samaila, D
    Toy, BJ
    Wang, RC
    Elegbede, JA
    ANTICANCER RESEARCH, 2004, 24 (5A) : 3089 - 3095
  • [23] Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro
    Dib, Maria
    Justian, Nathanil
    Scharf, Christian
    Busch, Chia-Jung
    Burchardt, Martin
    Caetano-Pinto, Pedro
    PHARMACOLOGY, 2023, 108 (01) : 90 - 100
  • [24] Cetuximab in Head and Neck Cancer Reply
    Vermorken, Jan B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (25) : 2726 - 2726
  • [25] Cetuximab in the treatment of head and neck cancer
    Bernier, Jacques
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (11) : 1539 - 1552
  • [26] Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC)
    Galper, S. L.
    Deshpande, H.
    Rose, M. G.
    Decker, R. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Cetuximab, cisplatin and amifostine during accelerated radiotherapy for locally advanced head and neck cancer
    Tsoutsou, P. G.
    Danielidis, V.
    Koukourakis, M. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] RADIOCHEMOTHERAPY WITH CETUXIMAB, CISPLATIN, AND AMIFOSTINE FOR LOCALLY ADVANCED HEAD AND NECK CANCER: A FEASIBILITY STUDY
    Koukourakis, Michael I.
    Tsoutsou, Pelagia G.
    Karpouzis, Antonios
    Tsiarkatsi, Maria
    Karapantzos, Ilias
    Daniilidis, Vassilios
    Kouskoukis, Constantinos
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 9 - 15
  • [29] Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
    Hoch, Matthew A.
    Cousins, Kati
    Nartey, Ruth
    Riley, Keith
    Hartranft, Megan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 553 - 554
  • [30] Should Cetuximab Replace Cisplatin for Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer?
    Riaz, Nadeem
    Sherman, Eric J.
    Fury, Matthew
    Lee, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 287 - 288
12345